Encysive Pharmaceuticals Announces Launch of THELIN in United Kingdom
November 06, 2006 03:30 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 6, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium)(2) 100 mg tablets in the United Kingdom for...
Encysive Submits Complete Response to FDA For Thelin New Drug Application
November 02, 2006 16:40 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 2, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced that following discussions today with the U.S. Food and Drug Administration (FDA), the Company has submitted a...
Encysive Pharmaceuticals Reports Third Quarter 2006 Financial Results
November 02, 2006 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 2, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the third quarter ended September 30, 2006.
Third Quarter Financial Overview
...
Encysive Pharmaceuticals Secures Equity Financing Commitment
October 19, 2006 18:45 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Oct. 19, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it has secured a commitment for up to $75 million in a common stock equity financing from Azimuth...
Encysive Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2006 Results
October 16, 2006 16:45 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Oct. 16, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Thursday, November 2, 2006 at 8:00 a.m. ET to discuss its third quarter 2006...
THELIN (Sitaxentan Sodium) Receives European Marketing Authorization for Treatment of Pulmonary Arterial Hypertension
August 11, 2006 13:16 ET
|
Encysive Pharmaceuticals Inc.
European Commission Grants First Selective, Once Daily Oral Endothelin A
Receptor Antagonist Approval in All 25 European Union Member States
Conference Call Scheduled for Monday, August...
Encysive Receives Notification of Marketing Authorization From European Commission Regarding THELIN (Sitaxentan Sodium)
August 10, 2006 15:18 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Aug. 10, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) was notified today that the European Commission has adopted the decision granting marketing authorization for THELIN(r)(1)...
Encysive Pharmaceuticals Reports Second Quarter 2006 Financial Results
August 07, 2006 07:02 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Aug. 7, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the second quarter ended June 30, 2006.
Second Quarter Financial Overview
--...
Encysive Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2006 Results
July 27, 2006 08:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, July 27, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Monday, August 7, 2006 at 8:00 a.m. ET to discuss its second quarter 2006...
Encysive Pharmaceuticals Reports First Quarter 2005 Financial Results
April 28, 2005 16:01 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, April 28, 2005 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the first quarter ending March 31, 2005.
"In the first quarter, we saw the...